| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $40.2M | -15.6% |
| SG&A Expense | $21.9M | -18.6% |
| Operating Income | -$66.6M | +17.5% |
| Pre-tax Income | -$63.2M | +11.0% |
| Net Income | -$63.2M | +11.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.7M | -81.6% |
| Short-term Investments | $39.4M | -13.2% |
| Current Assets | $51.7M | -48.8% |
| Total Assets | $67.7M | -43.5% |
| Current Liabilities | $7.7M | +5.3% |
| Total Liabilities | $21.0M | -4.0% |
| Stockholders' Equity | $46.7M | -52.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.0M | +19.8% |
| Capital Expenditures | $180K | -89.2% |
| Investing Cash Flow | $6.9M | +115.0% |
| Financing Cash Flow | $8K | -100.0% |
| Free Cash Flow | -$50.1M | +21.6% |